Citations (119)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Terence Ng, Yin Ting Cheung, Quan Sing Ng, Han Kiat Ho & Alexandre Chan. (2014) Vascular endothelial growth factor inhibitors and cognitive impairment: evidence and controversies. Expert Opinion on Drug Safety 13:1, pages 83-92.
Read now
Read now
Lodovico Balducci & Sophia Dorothe Fossa. (2013) Rehabilitation of older cancer patients. Acta Oncologica 52:2, pages 233-238.
Read now
Read now
Olav Dahl & Marianne Brydøy. (2012) Testicular germ cell tumours – still many challenges. Acta Oncologica 51:2, pages 147-150.
Read now
Read now
Mariann Iiristo, Tom Wiklund, Nils Wilking, Jonas Bergh & Yvonne Brandberg. (2011) Tailored chemotherapy doses based on toxicity in breast cancer result in similar quality of life values, irrespective of given dose levels. Acta Oncologica 50:3, pages 338-343.
Read now
Read now
Toril Rannestad. (2010) Factors related to quality of life in long-term survivors of gynecological cancer. Expert Review of Obstetrics & Gynecology 5:1, pages 105-113.
Read now
Read now
Katharine Jean Vearncombe & Nancy A. Pachana. (2009) Impact of health, treatment and psychological factors on cognitive functioning after chemotherapy for early breast cancer. Australian Psychologist 44:4, pages 235-247.
Read now
Read now
Dana M Chase, Bradley J Monk, Lari B Wenzel & Krishnansu S Tewari. (2008) Supportive care for women with gynecologic cancers. Expert Review of Anticancer Therapy 8:2, pages 227-241.
Read now
Read now
Articles from other publishers (112)
Jennifer Kim Penberthy, Anne Louise Stewart, Caroline F. Centeno & David R. Penberthy. (2023) Psychological Aspects of Breast Cancer. Psychiatric Clinics of North America 46:3, pages 551-570.
Crossref
Crossref
Elizabeth J. Cathcart-Rake & Kathryn J. Ruddy. (2023) Evidence-Based Guidance for Breast Cancer Survivorship. Hematology/Oncology Clinics of North America 37:1, pages 225-243.
Crossref
Crossref
İmdat Eroğlu & Burcu Çelik Eroğlu. (2022) Potential role of tryptophan catabolism in cancer-related cognitive impairment. Nutrition 103-104, pages 111765.
Crossref
Crossref
Sofía Luque Suárez, María Eugenia Olivares Crespo, Helena Olivera Pérez-Frade, Juana María Brenes Sánchez, Amanda López Picado, Miriam de la Puente Yagüe, Jorge Ruiz Rodríguez, Blanca González Palomares & María Herrera de la Muela. (2022) Perfil psicológico prequirúrgico de las mujeres con riesgo aumentado de cáncer de mama. Psicooncología 19:2, pages 255-268.
Crossref
Crossref
Varvara Krasnikova, Maria Pospelova, Olga Fionik, Tatyana Alekseeva, Konstantin Samochernykh, Nataliya Ivanova, Nikita Trofimov, Tatyana Vavilova, Elena Vasilieva, Albina Makhanova, Samwel Tonyan, Alexandra Nikolaeva, Evgeniya Kayumova & Maxim Shevtsov. (2022) Breast Cancer Treatment Decreases Serum Levels of TGF-β1, VEGFR2, and TIMP-2 Compared to Healthy Volunteers: Significance for Therapeutic Outcomes?. Pathophysiology 29:3, pages 537-555.
Crossref
Crossref
Guro Falk Eriksen, Jūratė Šaltytė Benth, Bjørn Henning Grønberg, Siri Rostoft, Øyvind Kirkevold, Sverre Bergh, Anne Hjelstuen, Darryl Rolfson & Marit Slaaen. (2022) Cognitive Trajectories in Older Patients with Cancer Undergoing Radiotherapy—A Prospective Observational Study. Current Oncology 29:7, pages 5164-5178.
Crossref
Crossref
Maria Pospelova, Varvara Krasnikova, Olga Fionik, Tatyana Alekseeva, Konstantin Samochernykh, Nataliya Ivanova, Nikita Trofimov, Tatyana Vavilova, Elena Vasilieva, Maria Topuzova, Alexandra Chaykovskaya, Albina Makhanova, Anna Mikhalicheva, Tatyana Bukkieva, Kenneth Restor, Stephanie Combs & Maxim Shevtsov. (2022) Potential Molecular Biomarkers of Central Nervous System Damage in Breast Cancer Survivors. Journal of Clinical Medicine 11:5, pages 1215.
Crossref
Crossref
Maria Pospelova, Varvara Krasnikova, Olga Fionik, Tatyana Alekseeva, Konstantin Samochernykh, Nataliya Ivanova, Nikita Trofimov, Tatyana Vavilova, Elena Vasilieva, Mariya Topuzova, Alexandra Chaykovskaya, Albina Makhanova, Tatyana Bukkieva, Evgeniya Kayumova, Stephanie Combs & Maxim Shevtsov. (2022) Adhesion Molecules ICAM-1 and PECAM-1 as Potential Biomarkers of Central Nervous System Damage in Women Breast Cancer Survivors. Pathophysiology 29:1, pages 52-65.
Crossref
Crossref
Renata Nunes Pedras, Maria Fernanda Marcusso Manhães, Aline Millani Carneiro, Getulio Yuzo Okuma, Simone Elias, Edvane Birelo Lopes De Domenico & Cristiane Decat Bergerot. (2022) Avaliação de Prejuízo Cognitivo em Sobreviventes de Câncer de Mama: Estudo Transversal. Psicologia: Teoria e Pesquisa 38.
Crossref
Crossref
Josipa Petric, Bahara Sadri, Phillipa van Essen & Nicola Ruth Dean. (2021) Improving preoperative breast reconstruction consultations: a qualitative study on the impact of personalised audio-recordings. BMC Women's Health 21:1.
Crossref
Crossref
Kathleen Van DykPatricia A. Ganz. (2021) Cancer-Related Cognitive Impairment in Patients With a History of Breast Cancer. JAMA.
Crossref
Crossref
Laura Tack, Tessa Lefebvre, Michelle Lycke, Christine Langenaeken, Christel Fontaine, Marleen Borms, Marianne Hanssens, Christel Knops, Kathleen Meryck, Tom Boterberg, Hans Pottel, Patricia Schofield & Philip R. Debruyne. (2021) A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON). EClinicalMedicine 39, pages 101081.
Crossref
Crossref
Dominique Chao, Andrew Hale, N. Lynn Henry, Anna L. Kratz & Nicolette M. Gabel. (2021) Cancer-Related Cognitive Impairment or “Chemobrain:” Emerging Assessments, Treatments, and Targets for Intervention. Current Physical Medicine and Rehabilitation Reports 9:3, pages 108-118.
Crossref
Crossref
Chloe Yi Shing Lim, Rebekah Clare Laidsaar‐Powell, Jane M. Young, Steven Chuan‐Hao Kao, Yuehan Zhang & Phyllis Butow. (2021) Colorectal cancer survivorship: A systematic review and thematic synthesis of qualitative research. European Journal of Cancer Care 30:4.
Crossref
Crossref
Rainer Souchon. (2021) Kognitive Einschränkungen bei Patientinnen durch adjuvante Systemtherapien. InFo Hämatologie + Onkologie 24:4, pages 30-32.
Crossref
Crossref
Florence D Mowlem, Brad Sanderson, Jill V Platko & Bill Byrom. (2020) Optimizing electronic capture of patient-reported outcome measures in oncology clinical trials: lessons learned from a qualitative study. Journal of Comparative Effectiveness Research 9:17, pages 1195-1204.
Crossref
Crossref
Areej A. Alhareeri, Kellie J. Archer, Han Fu, Debra E. Lyon, R. K. ElswickJrJr, Debra L. Kelly, Angela R. Starkweather, Lynne W. Elmore, Yahya A. Bokhari & Colleen K. Jackson-Cook. (2020) Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study. Breast Cancer Research 22:1.
Crossref
Crossref
Rainer Souchon. (2020) Kognitive Einschränkungen bei Patientinnen mit Brustkrebs in Frühstadien durch adjuvante Systemtherapien – Ergebnisse einer Substudie der TAILORx-StudieCognitive impairment in patients with early breast cancer receiving adjuvant systemic therapy: results from a substudy of the TAILORx trial. Strahlentherapie und Onkologie 196:12, pages 1142-1144.
Crossref
Crossref
Lynne I. Wagner, Robert J. Gray, Joseph A. Sparano, Timothy J. Whelan, Sofia F. Garcia, Betina Yanez, Amye J. Tevaarwerk, Ruth C. Carlos, Kathy S. Albain, John A. OlsonJrJr, Matthew P. Goetz, Kathleen I. Pritchard, Daniel F. Hayes, Charles E. Geyer, E. Claire Dees, Worta J. McCaskill-Stevens, Lori M. Minasian, George W. SledgeJrJr & David Cella. (2020) Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx. Journal of Clinical Oncology 38:17, pages 1875-1886.
Crossref
Crossref
Carmen Kohler, Ming Chang, Yu-Yin Allemann-Su, Marcus Vetter, Miyeon Jung, Misook Jung, Yvette Conley, Steven Paul, Kord M. Kober, Bruce A. Cooper, Betty Smoot, Jon D. Levine, Christine Miaskowski & Maria C. Katapodi. (2020) Changes in Attentional Function in Patients From Before Through 12 Months After Breast Cancer Surgery. Journal of Pain and Symptom Management 59:6, pages 1172-1185.
Crossref
Crossref
Johanna K. Ehrenstein, Sander K.R. van Zon, Saskia F.A. Duijts, Boukje A.C. van Dijk, Heleen F. Dorland, Sanne B. Schagen & Ute Bültmann. (2020) Type of cancer treatment and cognitive symptoms in working cancer survivors: an 18-month follow-up study. Journal of Cancer Survivorship 14:2, pages 158-167.
Crossref
Crossref
Mackenzi Pergolotti, Nicolò Matteo Luca Battisti, Lynne Padgett, Alix G. Sleight, Maya Abdallah, Robin Newman, Kathleen Van Dyk, Kelley R. Covington, Grant R. Williams, Frederiek van den Bos, YaoYao Pollock, Elizabeth A. Salerno, Allison Magnuson, Isabella F. Gattás-Vernaglia & Tim A. Ahles. (2020) Embracing the complexity: Older adults with cancer-related cognitive decline—A Young International Society of Geriatric Oncology position paper. Journal of Geriatric Oncology 11:2, pages 237-243.
Crossref
Crossref
C. Panciroli, G. Lucente, L. Vidal, E. Carcereny, V. Quiroga, J. C. Pardo, M. Romeo, A. Estival, J. L. Manzano, B. Pardo, J. M. Velarde, A. M. Esteve, D. Lopez, A. Mañes, V. Tuset, S. Villà & C. B. Quintero. (2019) Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab. Clinical and Translational Oncology 22:3, pages 411-419.
Crossref
Crossref
Joaquim C. Reis, Michael H. Antoni & Luzia Travado. (2019) Emotional distress, brain functioning, and biobehavioral processes in cancer patients: a neuroimaging review and future directions. CNS Spectrums 25:1, pages 79-100.
Crossref
Crossref
Joy Perrier, Armelle Viard, Christelle Levy, Nastassja Morel, Djelila Allouache, Sabine Noal, Florence Joly, Francis Eustache & Bénédicte Giffard. (2018) Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level. Brain Imaging and Behavior 14:1, pages 226-241.
Crossref
Crossref
Ammad Fahim, Zaira Rehman, Muhammad Faraz Bhatti, Nasar Virk, Amjad Ali, Amir Rashid & Rehan Zafar Paracha. (2019) The Route to ‘Chemobrain’ - Computational probing of neuronal LTP pathway. Scientific Reports 9:1.
Crossref
Crossref
Bihong T. Chen, Taihao Jin, Sunita K. Patel, Ningrong Ye, Huiyan Ma, Chi Wah Wong, Russell C. Rockne, James C. Root, Andrew J. Saykin, Tim A. Ahles, Andrei I. Holodny, Neal Prakash, Joanne Mortimer, James Waisman, Yuan Yuan, Daneng Li, Mina S. Sedrak, Jessica Vazquez, Vani Katheria & William Dale. (2019) Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study. Breast Cancer Research and Treatment 176:1, pages 181-189.
Crossref
Crossref
Ean-Jeong Seo, Sabine M. Klauck, Thomas Efferth & Alexander Panossian. (2019) Adaptogens in chemobrain (Part II): Effect of plant extracts on chemotherapy-induced cytotoxicity in neuroglia cells. Phytomedicine 58, pages 152743.
Crossref
Crossref
Catherine R. Marinac, Sandahl H. Nelson, Lisa Cadmus-Bertram, Jacqueline Kerr, Loki Natarajan, Suneeta Godbole & Sheri J. Hartman. (2018) Dimensions of sedentary behavior and objective cognitive functioning in breast cancer survivors. Supportive Care in Cancer 27:4, pages 1435-1441.
Crossref
Crossref
Noemi Dannecker, Niklas Bürgi & Peter Brugger. (2019) „Chemobrain“ – Stand der Forschung und Implikationen für die klinische Neuropsychologie. Zeitschrift für Neuropsychologie 30:1, pages 63-72.
Crossref
Crossref
Ean-Jeong Seo, Sabine M. Klauck, Thomas Efferth & Alexander Panossian. (2019) Adaptogens in chemobrain (Part I): Plant extracts attenuate cancer chemotherapy-induced cognitive impairment – Transcriptome-wide microarray profiles of neuroglia cells. Phytomedicine 55, pages 80-91.
Crossref
Crossref
C. Borghgraef & D. Razavi. 2019. Psycho-Oncologie de L'adulte. Psycho-Oncologie de L'adulte
235
245
.
Sahil Munjal & Paula C. Zimbrean. 2019. Perioperative Psychiatry. Perioperative Psychiatry
145
171
.
Anna Kovalchuk, Bryan Kolb & Olga Kovalchuk. 2019. Biomarkers of Human Aging. Biomarkers of Human Aging
185
202
.
Bihong T. Chen, Kiarash Ghassaban, Taihao Jin, Sunita K. Patel, Ningrong Ye, Can-Lan Sun, Heeyoung Kim, Russell C. Rockne, E. Mark Haacke, James C. Root, Andrew J. Saykin, Tim A. Ahles, Andrei I. Holodny, Neal Prakash, Joanne Mortimer, James Waisman, Yuan Yuan, George Somlo, Daneng Li, Richard Yang, Heidi Tan, Vani Katheria, Rachel Morrison & Arti Hurria. (2018) Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study. Magnetic Resonance Imaging 54, pages 218-224.
Crossref
Crossref
Kimberly D. van der Willik, Sanne B. Schagen & M. Arfan Ikram. (2018) Cancer and dementia: Two sides of the same coin?. European Journal of Clinical Investigation 48:11, pages e13019.
Crossref
Crossref
Bihong T. Chen, Taihao Jin, Sunita K. Patel, Ningrong Ye, Can-Lan Sun, Huiyan Ma, Russell C. Rockne, James C. Root, Andrew J. Saykin, Tim A. Ahles, Andrei I. Holodny, Neal Prakash, Joanne Mortimer, James Waisman, Yuan Yuan, Daneng Li, George Somlo, Jessica Vazquez, Abrahm Levi, Heidi Tan, Richard Yang, Vani Katheria & Arti Hurria. (2018) Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer. Breast Cancer Research and Treatment 172:2, pages 363-370.
Crossref
Crossref
H.F. Dorland, F.I. Abma, C.A.M. Roelen, R.E. Stewart, B.C. Amick, U. Bültmann & A.V. Ranchor. (2018) Work-specific cognitive symptoms and the role of work characteristics, fatigue, and depressive symptoms in cancer patients during 18 months post return to work. Psycho-Oncology 27:9, pages 2229-2236.
Crossref
Crossref
Amir Saeid Mohammadi, Xianchan Li & Andrew G. Ewing. (2018) Mass Spectrometry Imaging Suggests That Cisplatin Affects Exocytotic Release by Alteration of Cell Membrane Lipids. Analytical Chemistry 90:14, pages 8509-8516.
Crossref
Crossref
Deborah H. Allen, Jamie S. Myers, Catherine E. Jansen, John D. Merriman & Diane Von Ah. (2018) Assessment and Management of Cancer- and Cancer Treatment–Related Cognitive Impairment. The Journal for Nurse Practitioners 14:4, pages 217-224.e5.
Crossref
Crossref
August Kapogiannis, Sofia Tsoli & George Chrousos. (2018) Investigating the Effects of the Progressive Muscle Relaxation-Guided Imagery Combination on Patients with Cancer Receiving Chemotherapy Treatment: A Systematic Review of Randomized Controlled Trials. EXPLORE 14:2, pages 137-143.
Crossref
Crossref
Anna Kovalchuk, Lilit Nersisyan, Rupasri Mandal, David Wishart, Maria Mancini, David Sidransky, Bryan Kolb & Olga Kovalchuk. (2018) Growth of Malignant Non-CNS Tumors Alters Brain Metabolome. Frontiers in Genetics 9.
Crossref
Crossref
Andrew J. Roth & Adrienne Jaeger. 2018. The American Cancer Society's Principles of Oncology. The American Cancer Society's Principles of Oncology
379
392
.
Robert L. Barry, Nellie E. Byun, M. Noor Tantawy, Chase A. Mackey, George H. Wilson, Adam J. Stark, Michael P. Flom, Laura C. Gee & C. Chad Quarles. (2017) In vivo neuroimaging and behavioral correlates in a rat model of chemotherapy-induced cognitive dysfunction. Brain Imaging and Behavior 12:1, pages 87-95.
Crossref
Crossref
Tim A. Ahles & Arti Hurria. (2018) New Challenges in Psycho‐Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions. Psycho-Oncology 27:1, pages 3-9.
Crossref
Crossref
Sheri J. Hartman, Sandahl H. Nelson, Emily Myers, Loki Natarajan, Dorothy D. Sears, Barton W. Palmer, Lauren S. Weiner, Barbara A. Parker & Ruth E. Patterson. (2018) Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study. Cancer 124:1, pages 192-202.
Crossref
Crossref
Tracy D. Vannorsdall. (2017) Cognitive Changes Related to Cancer Therapy. Medical Clinics of North America 101:6, pages 1115-1134.
Crossref
Crossref
. (2017) National Institute on Aging /Alzheimer’s Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors. Journal of Oncology Research 1:1, pages 1-19.
Crossref
Crossref
Noem? Cerulla, ?ngels Arcusa, Jos?-Blas Navarro, Maite Garolera, Cristina Enero, Gl?ria Chico & Lu?s Fern?ndez-Morales. (2017) Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study. Breast Cancer Research and Treatment 164:1, pages 179-187.
Crossref
Crossref
Pok-Ja Oh. (2017) Predictors of cognitive decline in people with cancer undergoing chemotherapy. European Journal of Oncology Nursing 27, pages 53-59.
Crossref
Crossref
A. Asher, A. Ng & J. Engle. 2017. Cardio-Oncology. Cardio-Oncology
279
296
.
Diane F. Morean & Leora R. Cherney. (2016) Screening for Cognitive Impairment Associated with Chemotherapy for Breast Cancer. Current Breast Cancer Reports 8:3, pages 151-157.
Crossref
Crossref
Teresa Lesiuk. (2016) The Development of a Mindfulness-Based Music Therapy (MBMT) Program for Women Receiving Adjuvant Chemotherapy for Breast Cancer. Healthcare 4:3, pages 53.
Crossref
Crossref
Angela Scherwath. (2016) Neuropsychologische Beeinträchtigungen nach StammzelltransplantationNeuropsychological impairments after stem cell transplantation. Der Onkologe 22:7, pages 493-498.
Crossref
Crossref
John E. Schmidt, Ellen Beckjord, Dana H. Bovbjerg, Carissa A. Low, Donna M. Posluszny, Amy E. Lowery, Mary Amanda Dew, Stephanie Nutt, Sarah R. Arvey & Ruth Rechis. (2015) Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. Journal of Cancer Survivorship 10:2, pages 302-311.
Crossref
Crossref
Mackenzi Pergolotti, Grant R. Williams, Claudine Campbell, Lauro A. Munoz & Hyman B. Muss. (2016) Occupational Therapy for Adults With Cancer: Why It Matters. The Oncologist 21:3, pages 314-319.
Crossref
Crossref
Yu-Ling Chang, Yun-Fang Tsai, Yin-Kai Chao & Meng-Yu Wu. (2015) Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer. Quality of Life Research 25:2, pages 465-475.
Crossref
Crossref
Dénes Kleiner, Ágnes Szilvás, Klára Szentmihályi, Krisztina Süle & Anna Blázovics. (2016) Changes of erythrocyte element status of colectomysed cancerous patients: Retrospective study. Journal of Trace Elements in Medicine and Biology 33, pages 8-13.
Crossref
Crossref
P. Jean-Pierre & B.C. McDonald. 2016. Neuroepidemiology. Neuroepidemiology
297
309
.
L. M. Ercoli, L. Petersen, A. M. Hunter, S. A. Castellon, L. Kwan, B. A. Kahn-Mills, L. M. Embree, P. A. Cernin, A. F. Leuchter & P. A. Ganz. (2015) Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial. Psycho-Oncology 24:11, pages 1360-1367.
Crossref
Crossref
Lauro A. Munoz, Claudine Campbell & Patricia Bowyer. (2015) The Role of Occupational Therapy in Older Adults With Cognitive Impairments and an Oncology Diagnosis. Topics in Geriatric Rehabilitation 31:4, pages 281-286.
Crossref
Crossref
Reema D. Mehta & Andrew J. Roth. (2015) Psychiatric considerations in the oncology setting. CA: A Cancer Journal for Clinicians 65:4, pages 299-314.
Crossref
Crossref
Charissa Andreotti, James C. Root, Tim A. Ahles, Bruce S. McEwen & Bruce E. Compas. (2015) Cancer, coping, and cognition: a model for the role of stress reactivity in cancer-related cognitive decline. Psycho-Oncology 24:6, pages 617-623.
Crossref
Crossref
Teresa Lesiuk. (2015) The Effect of Mindfulness-Based Music Therapy ?on Attention and Mood in Women Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Study. Oncology Nursing Forum 42:3, pages 276-282.
Crossref
Crossref
James C. Root, Elizabeth Ryan, Gregory Barnett, Charissa Andreotti, Kemi Bolutayo & Tim Ahles. (2015) Learning and memory performance in a cohort of clinically referred breast cancer survivors: the role of attention versus forgetting in patient-reported memory complaints. Psycho-Oncology 24:5, pages 548-555.
Crossref
Crossref
K. Hermelink, V. Voigt, J. Kaste, F. Neufeld, R. Wuerstlein, M. Buhner, K. Munzel, D. Rjosk-Dendorfer, S. Grandl, M. Braun, F. E. von Koch, K. Hartl, S. Hasmuller, I. Bauerfeind, G. Debus, P. Herschbach & N. Harbeck. (2015) Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-related Post-traumatic Stress. JNCI Journal of the National Cancer Institute 107:7, pages djv099-djv099.
Crossref
Crossref
Cindy Borghgraef, Yves Libert, Anne-Marie Étienne, Nicole Delvaux, Christine Reynaert & Darius Razavi. (2014) La prise en charge des altérations cognitives en oncologie: une revue des études longitudinales contrôlées. Bulletin du Cancer 101:9, pages 866-875.
Crossref
Crossref
Marie Lange, B?n?dicte Giffard, Sabine Noal, Olivier Rigal, Jean-Emmanuel Kurtz, Natacha Heutte, Christelle L?vy, Djelila Allouache, Chantal Rieux, Johan Le Fel, Aur?lie Daireaux, B?n?dicte Clarisse, Corinne Veyret, Philippe Barth?l?my, Nadine Longato, Francis Eustache & Florence Joly. (2014) Baseline cognitive functions among elderly patients with localised breast cancer. European Journal of Cancer 50:13, pages 2181-2189.
Crossref
Crossref
Lucy Player, Lynette Mackenzie, Karen Willis & Siew Yim Loh. (2014) Women's experiences of cognitive changes or ‘chemobrain’ following treatment for breast cancer: A role for occupational therapy?. Australian Occupational Therapy Journal 61:4, pages 230-240.
Crossref
Crossref
Ying Zheng, Jianfeng Luo, Pingping Bao, Hui Cai, Zhen Hong, Ding Ding, James C. Jackson, Xiao-Ou Shu & Qi Dai. (2014) Long-term cognitive function change among breast cancer survivors. Breast Cancer Research and Treatment 146:3, pages 599-609.
Crossref
Crossref
Riccardo Soffietti, Elisa Trevisan & Roberta Rudà. 2014. Neurologic Aspects of Systemic Disease Part III. Neurologic Aspects of Systemic Disease Part III
1199
1218
.
Yin Ting Cheung, Si Rong Lim, Han Kiat Ho & Alexandre Chan. (2013) Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research. PLoS ONE 8:12, pages e81234.
Crossref
Crossref
Linda M. Ercoli, Steven A. Castellon, Aimee M. Hunter, Lorna Kwan, Barbara A. Kahn-Mills, Paul A. Cernin, Andrew F. Leuchter & Patricia A. Ganz. (2013) Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging and Behavior 7:4, pages 543-553.
Crossref
Crossref
Catherine M. Bender & Bethany D. Thelen. (2013) Cancer and Cognitive Changes: The Complexity of the Problem. Seminars in Oncology Nursing 29:4, pages 232-237.
Crossref
Crossref
Catherine M. Bender, Susan M. Sereika, Christopher M. Ryan, Adam M. Brufsky, Shannon Puhalla & Sarah L. Berga. (2013) Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?. Menopause 20:9, pages 905-913.
Crossref
Crossref
Lise Paquet, Barbara Collins, Xinni Song, Anne Chinneck, Marc Bedard & Shailendra Verma. (2013) A pilot study of prospective memory functioning in early breast cancer survivors. The Breast 22:4, pages 455-461.
Crossref
Crossref
Matthias Kröz, Matthias Fink, Marcus Reif, Siglinde Grobbecker, Roland Zerm, Michaele Quetz, Matthias Frühwirth, Benno Brinkhaus, Christian Bartsch, Matthias Girke & Christoph Gutenbrunner. (2012) Multimodal Therapy Concept and Aerobic Training in Breast Cancer Patients With Chronic Cancer-Related Fatigue. Integrative Cancer Therapies 12:4, pages 301-311.
Crossref
Crossref
Luke Solomons, Joyce Solomons & Margot Gosney. (2013) Dementia and cancer: a review of the literature and current practice. Aging Health 9:3, pages 307-319.
Crossref
Crossref
Erin O’Farrell, Joyce MacKenzie & Barbara Collins. (2013) Clearing the Air: A Review of Our Current Understanding of “Chemo Fog”. Current Oncology Reports 15:3, pages 260-269.
Crossref
Crossref
Erica L. Mayer. (2013) Early and Late Long-Term Effects of Adjuvant Chemotherapy. American Society of Clinical Oncology Educational Book:33, pages 9-14.
Crossref
Crossref
Debra L. Barton, Kelli Burger, Paul J. Novotny, Tom R. Fitch, Sadhna Kohli, Gamini Soori, Mary Beth Wilwerding, Jeff A. Sloan, Lisa A. Kottschade, Kendrith M. RowlandJr.Jr., Shaker R. Dakhil, Daniel A. Nikcevich & Charles L. Loprinzi. (2012) The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Supportive Care in Cancer 21:4, pages 1185-1192.
Crossref
Crossref
H. Taillia. (2013) Qu’en-est-il du chemobrain ?. Revue Neurologique 169:3, pages 216-222.
Crossref
Crossref
Yin Ting Cheung, Maung Shwe, Earl Hsien Jie Tan, Wai Keung Chui, Raymond Ng & Alexandre Chan. (2013) Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia. Journal of Cancer Survivorship 7:1, pages 146-154.
Crossref
Crossref
Kerstin Hermelink. 2013. Psychoonkologie. Psychoonkologie
79
82
.
Yin Ting Cheung, Maung Shwe, Wai Keung Chui, Wen Yee Chay, Soo Fan Ang, Rebecca Alexandra Dent, Yoon Sim Yap, Soo Kien Lo, Raymond Chee Hui Ng & Alexandre Chan. (2012) Effects of Chemotherapy and Psychosocial Distress on Perceived Cognitive Disturbances in Asian Breast Cancer Patients. Annals of Pharmacotherapy 46:12, pages 1645-1655.
Crossref
Crossref
Fatima Cardoso, Sibylle Loibl, Olivia Pagani, Alessandra Graziottin, Pietro Panizza, Laura Martincich, Oreste Gentilini, Fedro Peccatori, Alain Fourquet, Suzette Delaloge, Lorenza Marotti, Frédérique Penault-Llorca, Anna Maria Kotti-Kitromilidou, Alan Rodger & Nadia Harbeck. (2012) The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. European Journal of Cancer 48:18, pages 3355-3377.
Crossref
Crossref
Adva Avisar, Yaron River, Elad Schiff, Gil Bar-Sela, Mariana Steiner & Eran Ben-Arye. (2012) Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature. Breast Cancer Research and Treatment 136:1, pages 1-7.
Crossref
Crossref
Tim A. Ahles. (2012) Brain vulnerability to chemotherapy toxicities. Psycho-Oncology 21:11, pages 1141-1148.
Crossref
Crossref
Tim A. AhlesJames C. RootElizabeth L. Ryan. (2012) Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science. Journal of Clinical Oncology 30:30, pages 3675-3686.
Crossref
Crossref
Y.T. Cheung, M. Shwe, Y.P. Tan, G. Fan, R. Ng & A. Chan. (2012) Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Annals of Oncology 23:10, pages 2547-2552.
Crossref
Crossref
Dominique Rey, Anne-Déborah Bouhnik, Julien Mancini, Marc-Karim Bendiane, Valérie Séror & Patrice Viens. (2012) Self-Reported Cognitive Impairment After Breast Cancer Treatment in Young Women from the ELIPPSE40 Cohort: The Long-Term Impact of Chemotherapy. The Breast Journal 18:5, pages 406-414.
Crossref
Crossref
Y. Brandberg, S. Aamdal, L. Bastholt, M. Hernberg, U. Stierner, H. von der Maase & J. Hansson. (2012) Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b. European Journal of Cancer 48:13, pages 2012-2019.
Crossref
Crossref
N. BIGLIA, V.E. BOUNOUS, A. MALABAILA, D. PALMISANO, D.M.E. TORTA, M. D'ALONZO, P. SISMONDI & R. TORTA. (2012) Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. European Journal of Cancer Care 21:4, pages 485-492.
Crossref
Crossref
Yin Ting Cheung, Wai Keung Chui & Alexandre Chan. (2012) Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations. Critical Reviews in Oncology/Hematology 83:1, pages 99-111.
Crossref
Crossref
Tim Ahles, Sanne Schagen & Janette Vardy. 2012. Clinical Psycho‐Oncology. Clinical Psycho‐Oncology
71
82
.
Summer F. Acevedo. (2012) Why, after Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?. Breast Cancer: Basic and Clinical Research 6, pages BCBCR.S10293.
Crossref
Crossref
Ilana M. Braun, Sowmya R. Rao & William F. Pirl. (2012) Comparison of Self-reported Cognitive Difficulties in a National Sample of Long-Term Cancer Survivors and Cancer-Naive Controls. Psychosomatics 53:1, pages 68-74.
Crossref
Crossref
Herbert B. Newton. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II
903
916
.
Florence Joly, Olivier Rigal, Sabine Noal & Bénédicte Giffard. (2011) Cognitive dysfunction and cancer: which consequences in terms of disease management?. Psycho-Oncology 20:12, pages 1251-1258.
Crossref
Crossref
T. MITCHELL & P. TURTON. (2011) ‘Chemobrain’: concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study. European Journal of Cancer Care 20:4, pages 539-548.
Crossref
Crossref
Arash Asher. (2011) Cognitive Dysfunction Among Cancer Survivors. American Journal of Physical Medicine & Rehabilitation 90:5, pages S16-S26.
Crossref
Crossref
Michelle Ayala-FelicianoJaime J. Pons-ValerioJosé Pons-MaderaSummer F. Acevedo. (2011) The Relationship between Visuospatial Memory and Coping Strategies in Breast Cancer Survivors. Breast Cancer: Basic and Clinical Research 5, pages BCBCR.S6957.
Crossref
Crossref
Elena M. Kouri & Nancy L. Keating. 2011. Health Services for Cancer Survivors. Health Services for Cancer Survivors
53
83
.
Tim A. AhlesAndrew J. SaykinBrenna C. McDonaldYuelin LiCharlotte T. FurstenbergBrett S. HanscomTamsin J. MulrooneyGary N. SchwartzPeter A. Kaufman. (2010) Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve. Journal of Clinical Oncology 28:29, pages 4434-4440.
Crossref
Crossref
Arti Hurria & Harvey Jay Cohen. 2011. Practical Geriatric Oncology. Practical Geriatric Oncology
3
17
.
Nelli Boykoff, Mona Moieni & Saskia Karen Subramanian. (2009) Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. Journal of Cancer Survivorship 3:4.
Crossref
Crossref
KATHARINE J. VEARNCOMBE, MARGARET ROLFE, MARGARET WRIGHT, NANCY A. PACHANA, BROOKE ANDREW & GEOFFREY BEADLE. (2009) Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients. Journal of the International Neuropsychological Society 15:6, pages 951-962.
Crossref
Crossref
Grace Chang, Mary-Ellen Meadows, E. John Orav & Joseph H. Antin. (2009) Mental status changes after hematopoietic stem cell transplantation. Cancer 115:19, pages 4625-4635.
Crossref
Crossref
Sadhna Kohli, Susan G. Fisher, Yolande Tra, M. Jacob Adams, Mark E. Mapstone, Keith A. Wesnes, Joseph A. Roscoe & Gary R. Morrow. (2009) The effect of modafinil on cognitive function in breast cancer survivors. Cancer 115:12, pages 2605-2616.
Crossref
Crossref
Fleur Huang, Munir Alrefae, Adrian Langleben & David Roberge. (2009) Prophylactic Cranial Irradiation in Advanced Breast Cancer: A Case for Caution. International Journal of Radiation Oncology*Biology*Physics 73:3, pages 752-758.
Crossref
Crossref
Kerstin Hermelink, Volkmar Henschel, Michael Untch, Ingo Bauerfeind, Michael Patrick Lux & Karin Munzel. (2008) Short‐term effects of treatment‐induced hormonal changes on cognitive function in breast cancer patients. Cancer 113:9, pages 2431-2439.
Crossref
Crossref
Alessandra Suuberg. (2018) Mechanisms and Treatment of Chemotherapy-Induced Cognitive Impairment ('Chemobrain'). SSRN Electronic Journal.
Crossref
Crossref